Department of Endocrinology and Metabolism, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, 639 Zhizaoju Road, Shanghai, 200011, China.
Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
BMC Med. 2024 Mar 13;22(1):114. doi: 10.1186/s12916-024-03343-w.
Type 2 diabetes (T2D) is associated with an increased risk of premature death. Whether multifactorial risk factor modification could attenuate T2D-related excess risk of death is unclear. We aimed to examine the association of risk factor target achievement with mortality and life expectancy among patients with T2D, compared with individuals without diabetes.
In this longitudinal cohort study, we included 316 995 participants (14 162 with T2D and 302 833 without T2D) free from cardiovascular disease (CVD) or cancer at baseline between 2006 and 2010 from the UK Biobank. Participants with T2D were categorised according to the number of risk factors within target range (non-smoking, being physically active, healthy diet, guideline-recommended levels of glycated haemoglobin, body mass index, blood pressure, and total cholesterol). Survival models were applied to calculate hazard ratios (HRs) for mortality and predict life expectancy differences.
Over a median follow-up of 13.8 (IQR 13.1-14.4) years, deaths occurred among 2105 (14.9%) participants with T2D and 18 505 (6.1%) participants without T2D. Compared with participants without T2D (death rate per 1000 person-years 4.51 [95% CI 4.44 to 4.57]), the risk of all-cause mortality among those with T2D decreased stepwise with an increasing number of risk factors within target range (0-1 risk factor target achieved: absolute rate difference per 1000 person-years 7.34 [4.91 to 9.78], HR 2.70 [2.25 to 3.25]; 6-7 risk factors target achieved: absolute rate difference per 1000 person-years 0.68 [-0.62 to 1.99], HR 1.16 [0.93 to 1.43]). A similar pattern was observed for CVD and cancer mortality. The association between risk factors target achievement and all-cause mortality was more prominent among participants younger than 60 years than those 60 years or older (P for interaction = 0.012). At age 50 years, participants with T2D who had 0-1 and 6-7 risk factors within target range had an average 7.67 (95% CI 6.15 to 9.19) and 0.99 (-0.59 to 2.56) reduced years of life expectancy, respectively, compared with those without T2D.
Individuals with T2D who achieved multiple risk factor targets had no significant excess mortality risk or reduction in life expectancy than those without diabetes. Early interventions aiming to promote risk factor modification could translate into improved long-term survival for patients with T2D.
2 型糖尿病(T2D)与过早死亡的风险增加有关。多因素危险因素修正是否能降低 T2D 相关的死亡风险尚不清楚。我们旨在研究危险因素目标达标情况与 T2D 患者与无糖尿病患者的死亡率和预期寿命的关系。
在这项纵向队列研究中,我们纳入了 316995 名参与者(14162 名患有 T2D,302833 名无 T2D),他们在 2006 年至 2010 年期间无心血管疾病(CVD)或癌症。根据危险因素目标范围内的数量(不吸烟、身体活动、健康饮食、糖化血红蛋白、体重指数、血压和总胆固醇的推荐水平),将 T2D 患者分为不同类别。应用生存模型计算死亡率的风险比(HRs)并预测预期寿命差异。
在中位随访 13.8 年(IQR 13.1-14.4)期间,2105 名(14.9%)患有 T2D 的参与者和 18505 名(6.1%)无 T2D 的参与者死亡。与无 T2D 的参与者(每 1000 人年死亡率为 4.51[95%CI 4.44-4.57])相比,T2D 患者的全因死亡率呈阶梯式下降,随着危险因素目标范围内的数量增加(0-1 个危险因素达标:每 1000 人年绝对死亡率差异为 7.34[4.91-9.78],HR 2.70[2.25-3.25];6-7 个危险因素达标:每 1000 人年绝对死亡率差异为 0.68[-0.62-1.99],HR 1.16[0.93-1.43])。CVD 和癌症死亡率也存在类似的模式。在年龄小于 60 岁的参与者中,危险因素目标达标与全因死亡率之间的关系比 60 岁或以上的参与者更为显著(P 交互=0.012)。在 50 岁时,0-1 个和 6-7 个危险因素目标达标的 T2D 患者的预期寿命平均分别减少了 7.67(95%CI 6.15-9.19)和 0.99(-0.59-2.56)年,与无 T2D 的患者相比。
与无糖尿病患者相比,达到多个危险因素目标的 T2D 患者没有显著的超额死亡率风险或预期寿命缩短。旨在促进危险因素修正的早期干预措施可能会改善 T2D 患者的长期生存。